227 related articles for article (PubMed ID: 23200882)
1. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.
Hansen M; Hjortø GM; Donia M; Met Ö; Larsen NB; Andersen MH; thor Straten P; Svane IM
Vaccine; 2013 Jan; 31(4):639-46. PubMed ID: 23200882
[TBL] [Abstract][Full Text] [Related]
2. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
3. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization.
Ten Brinke A; Karsten ML; Dieker MC; Zwaginga JJ; van Ham SM
Vaccine; 2007 Oct; 25(41):7145-52. PubMed ID: 17719152
[TBL] [Abstract][Full Text] [Related]
4. Comparison of media and serum supplementation for generation of monophosphoryl lipid A/interferon-γ-matured type I dendritic cells for immunotherapy.
Kolanowski ST; Sritharan L; Lissenberg-Thunnissen SN; Van Schijndel GM; Van Ham SM; ten Brinke A
Cytotherapy; 2014 Jun; 16(6):826-34. PubMed ID: 24529557
[TBL] [Abstract][Full Text] [Related]
5. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
6. Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.
Hwang EC; Lim MS; Im CM; Kwon DD; Lee HJ; Nguyen-Pham TN; Lee YK; Lee JJ
Scand J Immunol; 2013 Feb; 77(2):117-24. PubMed ID: 23126536
[TBL] [Abstract][Full Text] [Related]
7. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
9. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
[TBL] [Abstract][Full Text] [Related]
10. Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
Hwang EC; Jung SI; Lee HJ; Lee JJ; Kwon DD
Int Braz J Urol; 2017; 43(4):615-627. PubMed ID: 28266813
[TBL] [Abstract][Full Text] [Related]
11. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.
Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B
J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554
[TBL] [Abstract][Full Text] [Related]
12. Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.
Gustafsson K; Junevik K; Werlenius O; Holmgren S; Karlsson-Parra A; Andersson PO
Scand J Immunol; 2011 Sep; 74(3):318-326. PubMed ID: 21595737
[TBL] [Abstract][Full Text] [Related]
13. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
Hong CY; Kim SY; Lee HJ; Lee SE; Lim SC; Rhee JH; Lee JJ
J Immunother; 2014 Jan; 37(1):16-25. PubMed ID: 24316552
[TBL] [Abstract][Full Text] [Related]
14. Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.
Pfeiffer IA; Hoyer S; Gerer KF; Voll RE; Knippertz I; Gückel E; Schuler G; Schaft N; Dörrie J
Eur J Immunol; 2014 Nov; 44(11):3413-28. PubMed ID: 25100611
[TBL] [Abstract][Full Text] [Related]
15. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
16. Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine.
Gustafsson K; Ingelsten M; Bergqvist L; Nyström J; Andersson B; Karlsson-Parra A
Cancer Res; 2008 Jul; 68(14):5965-71. PubMed ID: 18632652
[TBL] [Abstract][Full Text] [Related]
17. IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.
Hildenbrand B; Lorenzen D; Sauer B; Hertkorn C; Freudenberg MA; Peters JH; Nesselhut T; Unger C; Azemar M
Anticancer Res; 2008; 28(3A):1467-76. PubMed ID: 18630500
[TBL] [Abstract][Full Text] [Related]
18. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
19. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma.
Nakahara T; Urabe K; Fukagawa S; Uchi H; Inaba K; Furue M; Moroi Y
Clin Exp Immunol; 2005 Mar; 139(3):476-82. PubMed ID: 15730393
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy.
Raïch-Regué D; Naranjo-Gómez M; Grau-López L; Ramo C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
Vaccine; 2012 Jan; 30(2):378-87. PubMed ID: 22085546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]